This inventor holds 2 USPTO granted patents. Top assignee: Hangzhou Canhelp Genomics Technology Co. Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: **Innovations by Qifeng Wang: Advancements in Cancer Detection**
Introduction
Qifeng Wang, an accomplished inventor based in Hangzhou, China, has made significant contributions to the field of genomics and cancer detection. With two patents to his name, his work showcases the potential to improve diagnostic methods for bladder cancer and medulloblastoma.
Latest Patents
Qifeng Wang's latest patents include groundbreaking innovations in the area of cancer detection. One such patent details a set of genes for bladder cancer detection, encompassing 32 specific genes. These genes, including CA9, ERBB2, and VEGFA, form the basis for a kit designed to detect bladder cancer with high accuracy and objective interpretation of results. Notably, this non-invasive detection method enables improved patient compliance compared to traditional cystoscopy, offering important clinical benefits for early detection and postoperative monitoring.
The second patent addresses the molecular classification of medulloblastoma through a set of 24 genes, such as EPHA7, OTX2, and GABRA5. This innovation involves the development of a kit and gene chip that can accurately classify different subgroups of medulloblastoma, thereby aiding in precise treatment decisions. The high accuracy and short experimental period of this classification method highlight its clinical significance in oncology.
Career Highlights
Qifeng Wang is currently affiliated with Hangzhou Canhelp Genomics Technology Co., Ltd., where his research and innovations have thrived. His dedication to advancing cancer diagnostics is evident in his contributions to the field, emphasizing the potential for genetic research to transform patient care.
Collaborations
In his journey, Qifeng Wang has collaborated with notable colleagues, including Qinghua Xu and Chengshu Chen. Together, they have worked on various projects aimed at enhancing cancer detection and classification through genomics, highlighting the collaborative nature of scientific advancements.
Conclusion
Through his innovative work, Qifeng Wang exemplifies how targeted genetic research can lead to substantial improvements in cancer diagnostics. With his patented inventions, he is at the forefront of a movement that seeks to enhance early detection and treatment accuracy, paving the way for improved patient outcomes in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile